Trypanosoma cruzi calmodulin: cloning, expression and characterization

Area of Science:

• Molecular Biology
• Parasitology
• Biochemistry

Background:

• Calmodulin (CaM) is a highly conserved calcium-binding protein crucial for cellular signaling across diverse organisms.
• While CaM shows high sequence identity among vertebrates and trypanosomatids, the specific CaM from Trypanosoma cruzi (T. cruzi) presents potential functional variations.
• Understanding parasitic CaM is vital for developing targeted therapies against diseases like Chagas disease.

Purpose of the Study:

• To clone and express calmodulin (CaM) from Trypanosoma cruzi for the first time to enable large-scale protein production.
• To investigate and highlight the significant structural and functional differences between T. cruzi CaM and mammalian CaM.

Main Methods:

• Cloning and expression of Trypanosoma cruzi calmodulin (CaM).
• Development of a polyclonal antibody specific to T. cruzi CaM.
• Comparative analysis of CaM structure and function using circular dichroism spectroscopy.
• Assay of CaM antagonist activity (calmidazolium, trifluoperazine) on mammalian Ca(2+) pumps using T. cruzi CaM.

Main Results:

• A specific polyclonal antibody recognized T. cruzi CaM but not rat CaM, indicating distinct epitopes.
• T. cruzi CaM demonstrated a greater increase in alpha-helix content upon calcium binding compared to vertebrate CaM.
• Classical CaM antagonists showed significantly reduced inhibitory activity against T. cruzi CaM-stimulated mammalian Ca(2+) pumps.

Conclusions:

• Calmodulin from Trypanosoma cruzi possesses unique structural and functional properties that differentiate it from mammalian calmodulin.
• These distinct characteristics suggest potential for developing selective therapeutic agents targeting parasitic CaM.
• The findings underscore the importance of studying species-specific protein variations for drug discovery in parasitic diseases.